Sol-Gel Technologies (NASDAQ:SLGL) Trading Up 5.2% – Here’s What Happened

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) rose 5.2% during trading on Wednesday . The stock traded as high as $0.60 and last traded at $0.59. Approximately 11,111 shares were traded during trading, a decline of 96% from the average daily volume of 252,685 shares. The stock had previously closed at $0.56.

Sol-Gel Technologies Stock Performance

The company’s 50-day moving average price is $0.65 and its 200 day moving average price is $0.69. The stock has a market cap of $15.32 million, a PE ratio of -1.62 and a beta of 1.29.

Institutional Trading of Sol-Gel Technologies

A hedge fund recently bought a new stake in Sol-Gel Technologies stock. Raymond James Financial Inc. purchased a new position in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 108,990 shares of the company’s stock, valued at approximately $101,000. Raymond James Financial Inc. owned about 0.39% of Sol-Gel Technologies at the end of the most recent reporting period. 26.18% of the stock is owned by institutional investors and hedge funds.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.